Tag Archives: EMH

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Receives $26.5 Million from Exercise of Warrants and Triggers Acceleration of 721,700 Remaining $2.00 Warrants

Emerald Health Therapeutics Receives $26.5 Million from Exercise of Warrants and Triggers Acceleration of 721,700 Remaining $2.00 Warrants

VICTORIA, British Columbia, Dec. 21, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (“Emerald” or the “Company”) (TSXV: EMH; OTCQX: EMHTF) has elected to exercise its right to accelerate the exercise of $2.00 common share purchase warrants (“Warrants”) issued by the Company on February 10, 2017.

Emerald Health Northern Vine Labs

Northern Vine Labs Expands Dealer’s License with Health Canada

VICTORIA, British Columbia, Dec. 15, 2017 /Weed Wire/ — Northern Vine Labs (“Company”), a subsidiary of Emerald Health Therapeutics Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) and Abattis Bioceuticals Corp. (“Abattis”) (CSE: ATT; OTC: ATTBF), today announced that Health Canada has approved an amendment to the Company’s dealer’s license.

Emerald Health Northern Vine Labs

Emerald Health Announces No Material Change

VICTORIA, British Columbia, Dec. 13, 2017 /Weed Wire/ — Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF) (the “Company”) is issuing this press release in response to a request by the Investment Industry Regulatory Organization of Canada to comment on recent trading activity of its stock.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics, Inc. Acquires Shares of Vanc Pharmaceuticals Inc.

VICTORIA, British Columbia, Nov. 29, 2017 /Weed Wire/ — Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF) (“Emerald” or the “Company”) announces that it acquired today 1,666,6667 units (the “Units”) of Vanc Pharmaceuticals Inc. (“Vanc”) of Suite 810 – 789 West Pender Street, Vancouver, British Columbia, V6C 1H2 at a price of $0.15 per Unit pursuant to a private placement offering (the “Transaction”).

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Announces Positive Health Canada Review of License Application for Prominent Fouth Facility

VICTORIA, British Columbia, Nov. 28, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (TSXV: EMH; OTCQX: EMHTF) (“Emerald”) announced today that its licensed producer application (submitted through its subsidiary, Emerald Health Botanicals) for its new Richmond, BC greenhouse facility under Access to Cannabis for Medical Purpose Regulations (“ACMPR”) has met the requirements of the paper-based review of Health Canada’s Office of Medical Cannabis (“OMC”).

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Completes Investment in Licensed Dealer Northern Vine

VICTORIA, British Columbia, Nov. 21, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announced today that it has completed its previously announced investment of $2.5 million into Northern Vine Canada Inc. (“Northern Vine”) to acquire 53% of the company and appoint three of its four directors.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Appoints Robert C. Hill, CPA, CA as Chief Financial Officer and Promotes Cheryl Evans, CPA, CA to Vice President Finance

VICTORIA, British Columbia, Nov. 20, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (TSXV: EMH; OTCQX: EMHTF) (“Emerald”) today announced the appointment of Robert C. Hill, CPA, CA, as the Company’s Chief Financial Officer and the promotion of Cheryl L. Evans, CPA, CA, to Vice President Finance.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Announces Positive Health Canada Review of its Licensed Producer Application for Pure Sunfarms Facility

RICHMOND, British Columbia, Nov. 15, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (TSXV: EMH; OTCQX: EMHTF) announced today that its licensed producer application for the Pure Sunfarms Delta 3 greenhouse facility under Access to Cannabis for Medical Purpose Regulations (“ACMPR”) has met the requirements of the paper-based review of Health Canada’s Office of Medical Cannabis (”OMC”).

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Expands its Cannabis Supply with Purchase from Supreme Pharmaceuticals

VICTORIA, British Columbia, Sept. 20, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (EHT) (TSXV: EMH; OCTQX: EMHTF) today announced that its wholly owned subsidiary, Emerald Health Botanicals Inc., has completed a purchase of dried cannabis from Supreme Pharmaceuticals Inc.’s (Supreme) (TSXV: FIRE) subsidiary, 7ACRES.

SP Fire Emerald Health Leadership Team

Supreme Completes Sale with Emerald Health Botanicals Inc.

TORONTO, Ontario, Sept. 20, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV:FIRE) is pleased to announce its wholly owned subsidiary, 7ACRES, has completed a sale of dried cannabis to Emerald Health Botanicals Inc.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Launches Island Mist, One of Canada’s Highest CBD and CBD to THC Ratio Dried Flower Products

VICTORIA, British Columbia, Sept. 18, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (Therapeutics) (TSXV: EMH; OCTQX: EMHTF) has released Island Mist, its proprietary high cannabidiol (CBD) and high CBD to THC ratio dried flower product.

Emerald Health

Emerald Launches Market Leading CBD Oil and Supports Proposed Cannabis Legislation

VICTORIA, British Columbia, April 17, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (TSXV: EMH) (“Emerald” or the “Company”) today announced the launch of its CBD-25< and CBD-50 medical cannabis oils containing 25mg and 50mg of CBD per ml.

Legalization Anticipation: Canadian Cannabis Stocks Gain 12.3% on Monday

Legalization Anticipation: Canadian Cannabis Stocks Gain 12.3% on Monday

While the Canadian Marijuana Index dipped slightly in March due to federal uncertainties, the Canadian public markets have bounced back today on the news of recreational marijuana legislation being introduced in Canada’s House of Commons this Thursday, April 13, 2017.


Top